The SDHA Gene Leigh Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the SDHA gene, which are associated with Leigh syndrome. Leigh syndrome is a severe neurological disorder that typically emerges in the first year of life, characterized by progressive loss of mental and movement abilities. Mutations in the SDHA gene disrupt the function of the mitochondrial complex II, leading to this condition.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic mutations in the SDHA gene. This genetic test is crucial for early diagnosis, allowing for timely intervention and management of the syndrome.
DNA Labs UAE provides this comprehensive genetic testing service at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring accurate and reliable results. By identifying the genetic basis of Leigh syndrome, this test plays a vital role in the clinical management of affected individuals, offering insights into treatment options and prognosis.
The ACAD9 Gene Leigh Syndrome and Mitochondrial Encephalopathy Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ACAD9 gene, which are associated with Leigh syndrome and mitochondrial encephalopathy. Leigh syndrome, also known as subacute necrotizing encephalomyelopathy, is a severe neurological disorder that typically arises in the first year of life and is characterized by progressive loss of mental and movement abilities. Mitochondrial encephalopathy encompasses a range of disorders caused by dysfunction of the mitochondria, leading to neurological and muscular impairments.
The ACAD9 gene plays a crucial role in the function of mitochondria, the energy-producing structures within cells, making its mutations a critical factor in the development of these conditions. The test conducted at DNA Labs UAE involves analyzing the patient's DNA to detect any abnormalities in the ACAD9 gene that could lead to the development of Leigh syndrome or mitochondrial encephalopathy.
The cost of the ACAD9 Gene Leigh Syndrome and Mitochondrial Encephalopathy Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the genetic markers associated with these conditions, providing essential information for diagnosis, treatment planning, and genetic counseling. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step for patients and families seeking answers to complex genetic disorders affecting the nervous system and muscular function.
The "SURF1 Gene Leigh Syndrome due to COX Deficiency Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the SURF1 gene. These mutations are known to cause Leigh Syndrome, a severe neurological disorder that typically emerges in the first year of life. Leigh Syndrome associated with cytochrome c oxidase (COX) deficiency is specifically linked to the SURF1 gene alterations. This condition leads to progressive loss of mental and movement abilities, which can be fatal. The test, which costs 3200 AED, is crucial for early diagnosis and management of the syndrome. It involves analyzing the patient's DNA to identify any mutations in the SURF1 gene, providing vital information for treatment planning and genetic counseling for affected families. Conducted in the advanced facilities of DNA Labs UAE, this test is a key step towards personalized medicine for patients with Leigh Syndrome due to COX deficiency.
Leigh syndrome due to mitochondrial complex I deficiency is a severe neurological disorder that arises from genetic mutations affecting mitochondrial function, particularly the activity of complex I, a crucial enzyme in the mitochondrial respiratory chain. The MT-ND3 gene is one of the genes implicated in this condition. Mutations in the MT-ND3 gene can lead to impaired energy production in cells, resulting in the wide range of symptoms associated with Leigh syndrome, including developmental delay, muscle weakness, and breathing difficulties.
To diagnose this specific cause of Leigh syndrome, genetic testing is available at DNA Labs UAE. The test focuses on identifying mutations in the MT-ND3 gene that are known to contribute to mitochondrial complex I deficiency. This targeted genetic testing is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions.
The cost of the MT-ND3 gene Leigh syndrome due to mitochondrial complex I deficiency genetic test at DNA Labs UAE is 4400 AED. This investment covers the analysis of the MT-ND3 gene to detect mutations associated with the condition. By choosing this test, patients and their families can gain valuable insights into the genetic underpinnings of the disease, enabling more personalized and effective management strategies.
The MT-ND5 gene Leigh syndrome due to mitochondrial complex I deficiency is a genetic condition that affects the nervous system and other bodily functions. This condition is caused by mutations in the MT-ND5 gene, which is part of the mitochondrial DNA. These mutations lead to a deficiency in mitochondrial complex I, a crucial component of the mitochondrial respiratory chain responsible for energy production in cells. Symptoms of Leigh syndrome can include developmental delay, muscle weakness, breathing difficulties, and neurological problems.
To diagnose this specific form of Leigh syndrome, a genetic test is available at DNA Labs UAE. This test specifically looks for mutations in the MT-ND5 gene to confirm a diagnosis of Leigh syndrome due to mitochondrial complex I deficiency. The test is crucial for accurate diagnosis and management of the condition, allowing for tailored treatment plans and genetic counseling for affected families.
The cost of the MT-ND5 gene Leigh syndrome genetic test at DNA Labs UAE is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the detailed analysis conducted in the laboratory to detect any mutations in the MT-ND5 gene. Given the complexity of the test and the specialized technology used, the cost reflects the extensive resources required for accurate diagnosis.
For families and individuals facing symptoms indicative of Leigh syndrome, this genetic test provides a vital tool for understanding the underlying genetic cause and opens the door to targeted interventions and support services.
The "MT-ND6 Gene Leigh Syndrome due to Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the MT-ND6 gene, which are associated with Leigh syndrome stemming from mitochondrial complex I deficiency. Leigh syndrome is a severe neurological disorder that typically emerges in infancy or early childhood, characterized by progressive loss of mental and movement abilities. Mitochondrial complex I deficiency is one of the most common biochemical causes of this condition. The test involves analyzing the patient's DNA to detect any genetic anomalies in the MT-ND6 gene, aiding in the accurate diagnosis of Leigh syndrome. This information is crucial for understanding the disease's progression, potential treatment options, and genetic counseling for affected families. DNA Labs UAE provides this service with a focus on accuracy, confidentiality, and support for patients and their families navigating the complexities of genetic disorders.
The "NDUFA12 Gene Leigh Syndrome due to Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NDUFA12 gene, which are associated with Leigh syndrome. This condition is a severe neurological disorder that typically emerges in the first year of life, characterized by progressive loss of mental and movement abilities. Leigh syndrome is often linked to mitochondrial complex I deficiency, a critical issue in cellular energy production.
The test is carried out by DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability. By analyzing the patient's DNA, the test can pinpoint specific genetic alterations in the NDUFA12 gene, confirming a diagnosis of Leigh syndrome due to mitochondrial complex I deficiency. This information is crucial for understanding the disease's progression, potential interventions, and family planning considerations.
The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic markers associated with this condition. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of Leigh syndrome, facilitating informed decisions regarding management and treatment strategies.
The LIPT1 gene is associated with a rare genetic condition known as Leigh syndrome, specifically linked to deficiencies in the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. These complexes play critical roles in cellular energy production through the mitochondrial oxidative phosphorylation pathway. Mutations in the LIPT1 gene can disrupt these processes, leading to a spectrum of clinical manifestations including neurological and muscular impairments, among others.
To diagnose this specific form of Leigh syndrome, genetic testing for LIPT1-related mutations is essential. DNA Labs UAE offers a comprehensive genetic test aimed at identifying mutations in the LIPT1 gene. This test is crucial for confirming the diagnosis, understanding the disease's progression, and potentially guiding treatment options.
The cost of the LIPT1 gene Leigh syndrome genetic test at DNA Labs UAE is 4400 AED. This investment includes the process of collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the LIPT1 gene. The result from this test can provide invaluable information for affected individuals and their families, including genetic counseling and the possibility of participating in targeted therapies or clinical trials.
Pyruvate carboxylase deficiency is a rare genetic disorder that leads to Leigh syndrome, a severe neurological condition characterized by progressive loss of mental and movement abilities. The condition stems from mutations in the PC gene, which plays a critical role in energy production within cells. To diagnose this condition, a genetic test can be performed to identify mutations in the PC gene associated with the syndrome.
DNA Labs UAE offers a specialized genetic test for diagnosing PC gene Leigh syndrome due to pyruvate carboxylase deficiency. The test is designed to detect specific genetic mutations in the PC gene, providing crucial information for confirming the diagnosis and guiding treatment decisions. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the mutations associated with this condition.
Undergoing this genetic test at DNA Labs UAE can be an essential step for families seeking answers about symptoms related to Leigh syndrome and pyruvate carboxylase deficiency. Early diagnosis through genetic testing can enable timely intervention and management strategies to improve the quality of life for affected individuals.
The TACO1 gene Leigh syndrome due to the mitochondrial complex IV deficiency genetic test is a specialized diagnostic tool designed to identify mutations in the TACO1 gene, which are associated with Leigh syndrome, a severe neurological disorder. This condition is characterized by mitochondrial complex IV deficiency, leading to a range of symptoms such as psychomotor regression, hypotonia, and respiratory abnormalities. The test is crucial for early diagnosis and management of the syndrome, providing essential information for personalized treatment plans.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test offers a comprehensive analysis of the TACO1 gene to detect any mutations that could be responsible for the condition. With a cost of 4400 AED, it represents a significant investment in the health and well-being of individuals at risk of or suspected to have Leigh syndrome. Early detection through this genetic test can be pivotal in managing the syndrome's progression and improving the quality of life for affected individuals.
